Coherus Biosciences
Coherus Biosciences develops, manufactures and commercializes biologic therapeutics for oncology and inflammatory diseases. Learn more
Launch date
Employees
Market cap
€135m
Enterprise valuation
€236m (Public information from Sep 2024)
Share price
$1.13 CHRS
Redwood City California (HQ)
Authorizing premium user...